John C.  Pepia net worth and biography

John Pepia Biography and Net Worth

John C. Pepia joined the Company in February 2002 and served as Vice President, Accounting and Finance until May 2016, at which time Mr. Pepia was appointed Senior Vice President and Chief Accounting Officer. The Board of Directors appointed Mr. Pepia Principal Accounting Officer in August 2016. Prior to joining the Company, from 1996 to 2002, Mr. Pepia held several Vice President of Accounting & Finance positions at ANC Rental Corporation and its predecessor companies. He served in various financial positions in several public and private companies from 1985 to 1996.

What is John C. Pepia's net worth?

The estimated net worth of John C. Pepia is at least $251,816.23 as of January 22nd, 2019. Mr. Pepia owns 28,583 shares of Pediatrix Medical Group stock worth more than $251,816 as of April 19th. This net worth evaluation does not reflect any other assets that Mr. Pepia may own. Learn More about John C. Pepia's net worth.

How do I contact John C. Pepia?

The corporate mailing address for Mr. Pepia and other Pediatrix Medical Group executives is 1301 CONCORD TERRACE, SUNRISE FL, 33323. Pediatrix Medical Group can also be reached via phone at (954) 384-0175 and via email at [email protected]. Learn More on John C. Pepia's contact information.

Has John C. Pepia been buying or selling shares of Pediatrix Medical Group?

John C. Pepia has not been actively trading shares of Pediatrix Medical Group during the past quarter. Most recently, John C. Pepia sold 9,238 shares of the business's stock in a transaction on Friday, October 29th. The shares were sold at an average price of $26.87, for a transaction totalling $248,225.06. Learn More on John C. Pepia's trading history.

Who are Pediatrix Medical Group's active insiders?

Pediatrix Medical Group's insider roster includes Roger Hinson (Insider), Roger Medel, M.D. (Director), Mark Ordan (CEO), and John Pepia (Insider). Learn More on Pediatrix Medical Group's active insiders.

Are insiders buying or selling shares of Pediatrix Medical Group?

In the last twelve months, insiders at the sold shares 5 times. They sold a total of 70,920 shares worth more than $932,484.69. The most recent insider tranaction occured on December, 14th when EVP Mary Ann E Moore sold 970 shares worth more than $9,331.40. Insiders at Pediatrix Medical Group own 2.0% of the company. Learn More about insider trades at Pediatrix Medical Group.

Information on this page was last updated on 12/14/2023.

John C. Pepia Insider Trading History at Pediatrix Medical Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/29/2021Sell9,238$26.87$248,225.06View SEC Filing Icon  
1/22/2019Sell2,500$36.60$91,500.0028,583View SEC Filing Icon  
8/14/2018Sell3,500$48.18$168,630.0030,148View SEC Filing Icon  
6/12/2018Sell6,516$46.56$303,384.96View SEC Filing Icon  
5/22/2018Sell3,000$46.43$139,290.0039,716View SEC Filing Icon  
3/13/2018Sell3,000$58.35$175,050.0039,716View SEC Filing Icon  
12/12/2017Sell3,000$51.58$154,740.0035,569View SEC Filing Icon  
9/12/2017Sell3,000$42.85$128,550.0035,569View SEC Filing Icon  
2/16/2017Sell2,500$69.58$173,950.0031,025View SEC Filing Icon  
See Full Table

John C. Pepia Buying and Selling Activity at Pediatrix Medical Group

This chart shows John C Pepia's buying and selling at Pediatrix Medical Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pediatrix Medical Group Company Overview

Pediatrix Medical Group logo
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
Read More

Today's Range

Now: $8.98
Low: $8.79
High: $9.07

50 Day Range

MA: $9.21
Low: $8.46
High: $10.03

2 Week Range

Now: $8.98
Low: $7.70
High: $15.06

Volume

268,299 shs

Average Volume

700,034 shs

Market Capitalization

$754.55 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58